HIGHLIGHTS
- who: Saiful Islam and colleagues from the Drug Discovery and Development, Clinical and Health Sciences, University of South Australia have published the paper: Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition, in the Journal: Cancers 2023, 15, x FOR PEER REVIEW of /2023/
- what: The authors have further explored the selectivity of rilpivirine for inhibition by testing this drug against panel of 429 kinases. Apoptosis Regulatory Proteins Western blot analysis was carried out to examine the cellular biological responses resulting from the rilpivirine-mediated inhibition of Aurora A kinase activity in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.